IRIDEX Corporation
IRIXNASDAQHealthcare● Active
$1.11
+$0.02(+1.83%)
Market Cap$19321215
P/E Ratio—
52W High$1.65
52W Low$0.87
IRIDEX Corporation (IRIX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
IRIX · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 19, 2026EPS Actual
-$0.03
Est. -$0.07 · +57.1%
Revenue
$0.01B
Est. $0.01B · -0.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 19, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
IRIX reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$-0.01
Rev. $0.48B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$-0.01
Rev. Est.$0.48B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | -$0.01 | — | — | — | $0.01B | — |
| ▲ Q2 FY2026 | May 19, 2026 | -$0.07 | -$0.03 | +57.1% | $0.01B | $0.01B | -0.9% |
| ▲ Q1 FY2026 | Mar 26, 2026 | -$0.02 | -$0.01 | +50.0% | $0.01B | $0.01B | -0.1% |
| ▼ Q4 FY2025 | Nov 11, 2025 | -$0.02 | -$0.09 | -350.0% | $0.01B | $0.01B | -15.3% |
| ▲ Q3 FY2025 | Aug 12, 2025 | -$0.09 | -$0.06 | +33.3% | $0.01B | $0.01B | +3.6% |
| — Q2 FY2025 | May 13, 2025 | -$0.10 | -$0.10 | +0.0% | $0.01B | $0.01B | -1.7% |
| — Q1 FY2025 | Mar 27, 2025 | -$0.05 | -$0.05 | +0.0% | $0.01B | $0.01B | -0.8% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.09 | -$0.12 | -33.3% | $0.01B | $0.01B | -7.3% |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
-$0.01
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 19, 2026Beat
EPS Actual
-$0.03
EPS Est.
-$0.07
EPS Surpr.
+57.1%
Revenue
$0.01B
Q1 FY2026
Mar 26, 2026Beat
EPS Actual
-$0.01
EPS Est.
-$0.02
EPS Surpr.
+50.0%
Revenue
$0.01B
Q4 FY2025
Nov 11, 2025Miss
EPS Actual
-$0.09
EPS Est.
-$0.02
EPS Surpr.
-350.0%
Revenue
$0.01B
Q3 FY2025
Aug 12, 2025Beat
EPS Actual
-$0.06
EPS Est.
-$0.09
EPS Surpr.
+33.3%
Revenue
$0.01B
Q2 FY2025
May 13, 2025
EPS Actual
-$0.10
EPS Est.
-$0.10
EPS Surpr.
+0.0%
Revenue
$0.01B
Q1 FY2025
Mar 27, 2025
EPS Actual
-$0.05
EPS Est.
-$0.05
EPS Surpr.
+0.0%
Revenue
$0.01B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.12
EPS Est.
-$0.09
EPS Surpr.
-33.3%
Revenue
$0.01B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.01 | $0.01 | $0.01 | 1 |
| Q4 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q3 FY2026 | $-0.01 | $-0.01 | $-0.01 | 1 |
| Q2 FY2026 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q1 FY2026 | $-0.02 | $-0.02 | $-0.02 | 1 |
| Q4 FY2025 | $-0.06 | $-0.06 | $-0.06 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 19, 2026 | +57.1% | $1.01 | $1.05 | +3.96% |
| ▲ Q1 FY2026 | Mar 26, 2026 | +50.0% | $1.33 | $1.35 | +1.50% |
| ▼ Q4 FY2025 | Nov 11, 2025 | -350.0% | $1.10 | $1.19 | +8.18% |
| ▲ Q3 FY2025 | Aug 12, 2025 | +33.3% | $1.26 | $1.30 | +3.17% |
| ▲ Q2 FY2025 | May 13, 2025 | +0.0% | $1.15 | $1.10 | -4.35% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +0.0% | $0.90 | $0.88 | -1.85% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -33.3% | $1.43 | $1.41 | -1.40% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -33.3% | $1.82 | $1.87 | +2.75% |
Q2 FY2026+3.96%
Report Date
May 19, 2026
EPS Beat/Miss
+57.1%
Price Before
$1.01
Price After
$1.05
Q1 FY2026+1.50%
Report Date
Mar 26, 2026
EPS Beat/Miss
+50.0%
Price Before
$1.33
Price After
$1.35
Q4 FY2025+8.18%
Report Date
Nov 11, 2025
EPS Beat/Miss
-350.0%
Price Before
$1.10
Price After
$1.19
Q3 FY2025+3.17%
Report Date
Aug 12, 2025
EPS Beat/Miss
+33.3%
Price Before
$1.26
Price After
$1.30
Q2 FY2025-4.35%
Report Date
May 13, 2025
EPS Beat/Miss
+0.0%
Price Before
$1.15
Price After
$1.10
Q1 FY2025-1.85%
Report Date
Mar 27, 2025
EPS Beat/Miss
+0.0%
Price Before
$0.90
Price After
$0.88
Q4 FY2024-1.40%
Report Date
Nov 12, 2024
EPS Beat/Miss
-33.3%
Price Before
$1.43
Price After
$1.41
Q3 FY2024+2.75%
Report Date
Aug 8, 2024
EPS Beat/Miss
-33.3%
Price Before
$1.82
Price After
$1.87
Avg Beat Reaction+0.49%
Avg Miss Reaction+3.18%
Beat Rate5 / 8 quarters
Largest Move+8.18% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: IRIX ends December
IRIDEX Corporation (IRIX) most recently reported earnings on May 19, 2026 for Q2 FY2026, posting EPS of $-0.03 — beating the analyst consensus of $-0.07 by +57.1%. IRIX has beaten EPS estimates for 2 consecutive quarters. The next IRIX earnings date is expected around September 1, 2026.
Each quarter, investors track IRIX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. IRIX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
IRIX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
IRIX earnings · 5 questionsIRIDEX Corporation's next earnings report is expected around September 1, 2026. IRIX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; IRIX historically reports after market close (AMC).
IRIX earnings datewhen is IRIX earningsIRIX next earnings datewhen does IRIX report earningsIRIX earnings calendar
▸ Source: FMP · IRIDEX Corporation SEC filings · US GAAP · IRIDEX Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026